ATLANTA, GA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (NASDAQ: STAI, or ScanTech AI) , a security solution provider offering one of the world’s most advanced non-intrusive “fixed-gantry” CT screening technologies, announced today, following its successful merger with ScanTech Identification Beam Systems, LLC, that it now seeks to become a leading security solution provider for U.S. and global airport, cargo, homeland, and border security screening. ScanTech AI is a leading innovator of nex ...

NEENAH, WI., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal first quarter 2025 results after market close on Wednesday, January 22, 2025. Plexus’ management will host a conference call to discuss its fiscal first quarter results on Thursday, January 23, 2025 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com. What:Plexus Fiscal 2025 Q1 ...

NORTH PLAINS, Ore., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, will report its operational and financial results for its fiscal 2025 first quarter, after the market close on Tuesday, January 14, 2025. The Company has scheduled a conference call and webcast that same day, Tuesday, January 14, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answ ...

MALVERN, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc., (NYSE: VSH), will release its results for the fiscal fourth quarter ended December 31, 2024, before the New York Stock Exchange opens on Wednesday, February 5, 2025. A conference call to discuss Vishay’s fourth quarter financial results is scheduled for Wednesday, February 5, 2025 at 9:00 a.m. ET. To participate in the live conference call, please pre-register at https://register.vevent.com/register/BI8ebcbdf5aaea4c50833bdc15cc86f ...

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance and sale of an aggregate of ...

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its fourth quarter and year-end 2024 earnings in a press release to be issued after the market closes on Tuesday, February 4, 2025. Senior management will hold a conference call for its fourth quarter and year-end 2024 earnings on Wednesday, February 5, 2025 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust, In ...

PURCHASE, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that CEO Lisa Ricciardi will be participating at upcoming conferences taking place during the week of the JP Morgan Healthcare Conference 2025. “I am looking forward to these opportunities to discuss the incredible progress we have made in 2024 with our Alzheimer’s and dementia with Lewy body ...

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company overview and conduct one-on-one meetings at Biotech Showcase, which is being held January 13-15, in San Francisco. Details of the presentation are as follows:Date: Wednesday, January 15thTime: 9:45am PT In addition to a corporate update, FluidForm will share updated data on its lead program in ...

A Key Milestone for Therapeutic Exosome ProductionTORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a developer of exosome-based therapies for regenerative medicine, is pleased to announce that it has acquired a master cell bank from a U.S. manufacturer for an undisclosed amount (the “Acquisition”). The Acquisition marks a major step in ensuring a stable and scalable supply chain for production of ex ...

CARLSBAD, Calif., Jan. 8, 2025 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference at 10:30 a.m. PT on Wednesday, January 15, 2025. A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events. A replay will be available on the Ionis website within 48 hours and will be archiv ...